menu search

Vigil Neuroscience to Present at the 41st Annual J.P. Morgan Healthcare Conference

Vigil Neuroscience to Present at the 41st Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) — Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that Ivana Magovčević-Liebisch, Ph.D., J.D., President and Chief Executive Officer, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on […] The post Vigil Neuroscience to Present at the 41st Annual J.P. Morgan Healthcare... Read More
Posted: Jan 3 2023, 12:00
Author Name: forextv
Views: 110847

Search within

Pages Search Results: